Fresenius Medical Care, a German company specializing in the supply of medical products and services, has been fined $ 231 million in the United States for bribes in several foreign countries. The company, a subsidiary of Fresenius, was found guilty of using various bribery schemes “to gain foreign business opportunities”. Morocco is among the countries concerned by these practices, according to the US Department of Justice.
According to a statement from the Department of Justice, “Fresenius paid bribes to Morocco through a bogus commission to a Moroccan official to obtain contracts to develop kidney dialysis centers in Moroccan public military hospitals”. “The bogus commission would pay 10% of the value of the contract to the Moroccan official and disguised this sum in a bonus paid to an employee of Fresenius,” reads the statement.
In Morocco, Angola, Saudi Arabia, Spain, Turkey, and West African countries, Fresenius also acknowledged “knowingly failed to put in place reasonable internal accounting controls over financial transactions to keep records that correctly reflect the transactions”.